Hetero Biopharma organised live interactive Webinar sessions for Oncologists, Haematologist of Emerging markets
Hetero Biopharma biologics arm of Hetero, with a mission of REACHing every stakeholder across the globe, organised webinars (Web based CMEs) under its knowledge exchange platform KBB (Knowledge Beyond Borders) for oncologists, haematologists of Asia and Africa
HBP hosted two sessions(many more lined up) of webinars, with eminent oncologist in India Dr Suresh Atilli as speaker. Initial session was held on 30th April 2020, on “Shooting in the dark in metastatic solid tumours” sharing his experiences in treating solid tumours with Bevacizumab (Bevaas) has brought together 45+ Oncologists from 9 countries of Emerging markets
Subsequent session was held on 02nd May 2020, on “Being specific in B Cell tumours” with Rituximab (Rilast) which could appose more than 75+ participants from 12 countries in the fields of Oncology and Haematology
The forum has raised the bar on role of biosimilars in addressing the challenges in treating complicated solid and blood cancers.
It was bi way interactive concourse, with doctors of multiple regions expressing their ways of practice, presenting real time experience in treating cancers. The hearing served as an eye opener for many of the upcoming and practicing oncologists on importance of addition of biosimilars in treatment protocols
Indeed, it was Hetero Biopharma’s team effort put in by field force and strategic business partners to bring the doctors, onto this virtual platform to utilise this lock down period in learning updated treatment modalities in cancer therapy. We are glad to announce further sessions are lined up in fields of Nephrology and Rheumatology..
